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Abstract: 
Current trends in bio-medicine include research synthesis and dissemination of bioinformation by means of health (bio) 
information technology (H[b] IT). Research must secure the validity and reliability of assessment tools to quantify research quality 
in the pursuit of the best available evidence. Our concerted work in this domain led to the revision of three instruments for that 
purpose, including the stringent characterization of inter-rater reliability and coefficient of agreement.  It is timely and critical to 
advance the methodological development of the science of research synthesis by strengthening the reliability of existing measure of 
research quality in order to ensure H[b] IT efficacy and effectiveness.  
 
 
Keywords: Health (bio) information technology (H[b] IT), research quality validation, reliability, acceptable sampling analysis, 
efficacy, effectiveness 
 
 
 
Background:  
Current trends in bio-medicine include timely and critical new 
developments in the assimilation, synthesis and dissemination 
of bioinformation. Health (bio) information technology (H[b] 
IT) has now gained universal recognition across all fields of 
healthcare worldwide. H[b] IT refers to the cluster of 
approaches that pertain to the management of health 
information across computerized systems, and its secure 
dissemination among stakeholders (i.e., patients, caregivers, 
clinicians, governmental and private healthcare entities, and 
healthcare insurance providers). In 2001, the US Institute of 
Medicine launched a call for establishing electronic 
documentation systems in all aspects of healthcare.  Current 
trends establish H[b]IT as one among the most promising tools 
for improving the overall quality, safety as well as effectiveness 
and efficacy (i.e., efficiency) of the health delivery system [1]. 
H[b[IT is most simply defined as an application of information 
processing that involves both computer hardware and software 
and that deals with the storage, retrieval, sharing, and use of 
health care information, data, and knowledge for 
communication and clinical decision-decision making. H[b]IT 
stands today at the forefront of development and innovation in 
new technologies in hardware (e.g., increased size capacity of 
servers to store bioinformation; faster and more reliable 
provider point of entry technologies), in software (e.g., 
improved electronic health record software for the collection, 
storage and retrieval of patient information, medical histories, 
laboratory and imaging data, clinical diagnoses and prognostic 
observations), and in improved advanced health 
(bio)information informatics (i.e., synthesis of the research 
evidence pertaining to the patient’s condition into the 
consensus of the best available evidence). The best available 
evidence leads to new and improved clinical practice 
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guidelines, and is translated for dissemination, via H[b] IT, to 
the stakeholders [2, 3]. 
 
Three prominent current trends examples of the importance of 
H[b] IT in general and of advanced health (bio) information 
informatics are: (1) British National Health Service Program for 
IT, NPfIT, 2006; (2) rising budgets of the Agency for Health 
Research Quality (AHRQ) and the Patient-Centered Outcomes 
Research Institute (PCORI) since Pres. Obama signed the 
Patient Protection and Affordable Care Act (PPACA, 2010; 
upheld, US Supreme Court 06/29/12) [Case in point: the July 
2012 National Workshop to Advance the Use of Electronic Data 
in Patient-Centered Outcomes Research held by PCORI, and the 
June 2012 PCORI White Paper by Gabriel et al. and the PCORI 
Methodology Committee, cf. www.pcori.org]; (3) Cochrane 
organization, now established world-wide and across all 
continents: the premier entity for generating and disseminating 
systematic reviews, and establishing the fundamental research 
synthesis methodology, including the risk of bias assessment 
tool. (2005-present, development and dissemination of the Risk 
of Bias tool by the Methods unit, Cochrane Statistical Methods 
Group, for examining flaws in the design, conduct, analysis, 
and reporting of research studies, in particular clinical trials, 
that might cause the effect of an intervention to be 
underestimated or overestimated.  The content validity of the 
tool is ensured because it covers six domains of possible bias: 
selection bias, performance bias, detection bias, attrition bias, 
reporting bias, and other possible biases. Within each domain, 
qualitative assessments and ranking (i.e., high, moderate, low) 
are made for one or more items, which may cover different 
aspects of the domain, or different outcomes.  To date, the 
reliability of the tool is inconclusive and has not been 
established [4]. Systematic reviews are research reports that are 
distinct from traditional biomedical research reports in that 
they consist of a synthesis of all of the available peer-reviewed 
and non-peer-reviewed research. The objective of systematic 
reviews is to identify the best research evidence for the clinical 
outcomes sought. Systematic reviews are also distinct from 
traditional literature reviews in that they follow a systematic 
protocol, which characteristically adheres stringently to a 
patient-centered and patient-tailored research question. 
Systematic reviews are scientific reports of research synthesis 
designs strictly driven by the patient’s clinical problem, the 
potential interventions under considerations, and the desired 
clinical outcome (hence the acronym, P.I.C.O.) [5]. The P.I.C.O. 
statement yields the necessary keywords and medical subject 
headings to gain access to all of the pertinent available evidence 
– the bibliome. The bibliome must be accessed through at least 
three databases, thus generating redundancy and ensuring 
capture of all of the available evidence.  The bibliome search 
(i.e., “bibliometric analysis”) is refined to retain only the 
research that is truly pertinent to the P.I.C.O. question.  To 
ensure reliability, the bibliometric analysis is performed by two 
or more investigators carefully trained and standardized [6, 7].  
 
Each report in the bibliome is examined for two fundamental 
questions:  1) “what type of study was performed to obtain the 
evidence?”, and 2) “how well was the study performed?”. Both 
questions are of highest relevance to the research synthesis 
process of the systematic review, because both questions have 
profound implications for the consensus of the best available 
evidence that will be obtained. The first question (“what type of 
study was performed”) seeks to establish whether the design 
was an observational study or a clinical trial, an experimental 
animal or bench study or a diagnostic study, etc. It pertains to 
the level of the evidence – a higher level of evidence being 
given to clinical trials than observational studies, for example. 
The second question (“how well was the study performed”) 
speaks to whether the reported study followed, or strayed from 
the fundamental and widely accepted standards of research 
methodology, design and data analysis – the “quality of the 
evidence”.  The first question addresses “what” was done, 
whereas the second question points to “how well” it was done 
[4-6], above and beyond the assessment of the risks of bias. 
These assessments yield data that are analyzed statistically for: 
1) which studies in the research synthesis protocol most adhere 
to the standards of research methodology, design and data 
analysis, and hence are acceptable for putative utilization in a 
patient-centered intervention modality, vs. which studies 
deviate from said standards and are – based on acceptable 
sampling statistics [6, 7] – unacceptable for patient treatment, 
and inclusion in the consensus of the best available evidence; 2) 
meta-analysis of the acceptable reports to establish the 
statistically-speaking best available evidence.  When 
appropriate the stated clinical relevance among all acceptable 
reports may also be extracted and analyzed statistically by 
means of thematic inference [8].  
 
Having thusly obtained the consensus of the best available 
evidence, systematic review findings and conclusions are 
disseminated to providers, patients, caregivers and other 
stakeholders [2, 3]. 
 
Of all the steps outlined above, the greater challenge to H (b) IT 
presently remains establishing the reliability of assessment of 
the quality of the evidence.  Most of the scales available for this 
purpose are derived, or expanded from the original JADAD 
scale [9], and are often limited to rating subject randomization, 
blinding, and drop-out. These domains are hardly 
representative of the vast number of criteria that establish the 
standards of research methodology, design and data analysis. 
Other available instruments often suffer from fundamental 
flaws of reliability, including most importantly standardization 
of the readers as noted by Hartling and collaborators in a 2012 
AHRQ report (“Inter-rater variability resulted more often from 
different interpretation of the tool rather than different 
information identified in the study reports…”) [10]. The report 
further states in no uncertain terms the “need to determine 
inter-rater reliability and validity in order to support the uptake 
and use of individual tools that are recommended by the 
systematic review community…” (p. 2).  In brief, current trends 
demand an articulated research program for validating these 
tools, because of the fundamental importance and relevance of 
sound assessments of research quality to the process of 
obtaining the best available evidence for H[b] IT.  
 
With respect to the validity of such instruments, our EBD Study 
Research Group (EBD-PBRN) has considered the meta-
construct of “research quality” as consisting of three constructs:  
methodology, design, and data analysis.  We populated each 
domain with content specific to the fundamental standards of 
methodology, design, and analysis.  Individual items in each 
group were crafted to incorporate criteria of excellence of 
sampling & allocation, instrumentation, and validity 
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(methodology), trials, observational and diagnostic designs 
(design), and descriptive and inferential statistics (data analysis) 
[11]. To ensure reliability, we preceded along the stringent 
protocol outlined in Table 1 (see supplementary material). 
Stability (intra-rater coefficient) and homogeneity (Cronbach 
alpha internal consistency coefficient) proffered little or no 
added information to this process. Through classic test theory, 
we revised the scoring protocols of the AMSTAR [6] and the 
GRADE instruments [7], common tools for assessing quality of 
systematic reviews and of primary research.  We did not alter 
the item content, thus preserving the instruments’ content and 
construct validity.  We augmented the scope of the GRADE 
instrument with a sub-scale targeted to assess clinical relevance 
[7], and validated that sub-scale following the protocol outlined 
above. By means of a process of qualitative factor and cluster 
analysis of the literature, we identified a set of four criteria for 
each item in each scale, such that one point was attributed for 
each criterion satisfied – thus each item had now a semi-
continuous range of measurement from 1 to 4. By proceeding 
through the steps a-f outlined above, we verified the reliability 
of our revised AMSTAR (R-AMSTAR, 6), and expanded 
GRADE (Ex-GRADE, 7), independently from a similar line of 
work engaged by AHRQ, which however yielded less definitive 
outcomes than ours [12]. The scores for each item across the 
bibiome could be analyzed for acceptable sampling by means of 
the Freedman nonparametric test.  
 
In brief, our work offers a research protocol to establish and 
improve the reliability of research quality assessment tools.  
Current trends in H[b]IT, clearly have the potential to enhance 
the efficacy and the effectiveness of patient-centered care, 
“despite marked heterogeneity in study characteristics and 
quality, substantial evidence exists confirming that health IT 
applications with [patient-centered care] PCC-related 
components have a positive effect on health care outcomes...” 
[13]. The available tools now demand further applications of the 
approach outlined in Table 1 (see supplementary material) for 
improving the fundamental methodology of research synthesis, 
as outlined in cf., “Our Questions, Our Decisions: Standards for 
Patient-centered Outcomes Research”, PCORI Methodology 
Committee, Spring 2012, and specifically in terms of the 
validation and reliability characterization of study quality 
instruments e.g., AGREE-II, [14]. 
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Supplementary material: 
 
Table 1:  Protocol to establish the reliability of research quality assessment tools 
A train multiple readers in sharing a common view for the cognitive interpretation of each item 
B train the readers to read and evaluate independently and blindly the quality of a set of papers 
C refine the process until the inter-rater correlation coefficient and Cohen coefficient of agreement are 0.80-0.85 (over 65% shared 
variance) 
D obtain independent and blind reading assessments from readers on reports under study 
E compute means and standard deviation of scores for each question across the reports, repeat process if the coefficient of 
variations are greater than 5% (i.e., less than 5% error among the readers across each questions) 
 
